Metraipolis › archive › dc_fda8b5ddc449
Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy — Europe PMC PMID:41596556
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41596556
- DOI
- 10.3390/ijms27020909
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T17:58:38.080Z
- SHA-256 of the archived text
2797cf0521aea1a1b17e25ddca11a3182724fde53f4ff3600bcf4788d1c35bf3- Stable URL of this page
https://metraipolis.com/documento/dc_fda8b5ddc449
How to cite
Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy — Europe PMC PMID:41596556 — Europe PMC (en), https://europepmc.org/article/MED/41596556 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fda8b5ddc449 (Metraipolis archive dc_fda8b5ddc449, sha256 2797cf0521aea1a1b17e25ddca11a3182724fde53f4ff3600bcf4788d1c35bf3)
BibTeX
@misc{dcfda8b5ddc449,
title = {Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy — Europe PMC PMID:41596556},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41596556},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fda8b5ddc449; sha256 2797cf0521aea1a1b17e25ddca11a3182724fde53f4ff3600bcf4788d1c35bf3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596556. Agents can read the archived copy with the MCP tool read_document.